Geneva, Aug. 6 -- International Clinical Trials Registry received information related to the study (NCT07731828) titled 'Neoadjuvant Short-course Hypofractionated Radiotherapy Plus Adebrelimab and Platinum Chemotherapy in Locally Advanced Cervical Cancer: A Single-arm Phase II Trial' on July 23.

Study Type: Interventional

Study Design: Allocation: N/A. Intervention model: Single Group Assignment. Primary purpose: Treatment. Masking: None (Open Label).

Primary Sponsor: The First Affiliated Hospital with Nanjing Medical University

Condition: Cervical Neoplasms

Intervention: Drug: Adebrelimab

Recruitment Status: Recruiting

Phase: Phase 2

Date of First Enrollment: August 1, 2026

Target Sample Size: 35

Countries of Recruitment...